Recruiting Alopecia Studies in Boca Raton
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 ye...
Safety and Efficacy of VDPHL01 in Males With AGA
This study will evaluate the safety and efficacy of VDPHL01 in male subjects with Androgenetic Alopecia (AGA). AGA (or male pattern baldness) is a genetic disorder caused by an excessive (too much) h...
About Alopecia Clinical Trials in Boca Raton
Alopecia refers to hair loss from any part of the body, with alopecia areata being an autoimmune form causing patchy hair loss. It can range from small patches to total body hair loss. Treatments include JAK inhibitors, corticosteroids, and immunotherapy.
There are currently 2 alopecia clinical trials recruiting participants in Boca Raton, FLORIDA. These studies are seeking a combined 1,075 participants. Research is being sponsored by Eli Lilly and Company, Veradermics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alopecia Clinical Trials in Boca Raton — FAQ
Are there alopecia clinical trials in Boca Raton?
Yes, there are 2 alopecia clinical trials currently recruiting in Boca Raton, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boca Raton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boca Raton research site will contact you about next steps.
Are clinical trials in Boca Raton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boca Raton studies also compensate for your time and travel.
What alopecia treatments are being tested?
The 2 active trials in Boca Raton are testing new therapies including novel drugs, biologics, and treatment approaches for alopecia.
Data updated March 2, 2026 from ClinicalTrials.gov